Skip to content
YCW18· Other

FidoCure®

FidoCure® is the leader in Precision Medicine for Canine Oncology.

ActiveChecked 20h ago
Batch
W18
Status, per YC
Active
Team size
14
HQ
San Francisco, CA
In W18146 companies, 25% AI
fidocure.comYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About FidoCure®

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

San Francisco, CA, USA; Palo Alto, CA, USA; Remote

FidoCure®: questions

Which YC batch was FidoCure® in?

FidoCure® was in Y Combinator's Winter 2018 batch (W18).

Is FidoCure® still active?

Y Combinator lists FidoCure® as active.

Where is FidoCure® based?

FidoCure® lists San Francisco, CA, USA; Palo Alto, CA, USA; Remote as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.